Advanced search
Publication Cover
JAK-STAT Volume 1, 2012 - Issue 4
Journal homepage
1,576
Views
52
CrossRef citations to date
0
Altmetric
Review

STAT3 signaling in pulmonary arterial hypertension

Roxane Paulin Vascular Biology Research Group; Department of Medicine; University of Alberta; Edmonton, AB CanadaCorrespondence[email protected]
,
Jolyane Meloche Pulmonary Hypertension Group; CRIUCPQ; Department of Medicine; Laval University, Quebec City, QC Canada
&
Sébastien Bonnet Pulmonary Hypertension Group; CRIUCPQ; Department of Medicine; Laval University, Quebec City, QC Canada
Pages 223-233 | Published online: 01 Oct 2012

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Bhuvaneshwar Vaidya, Matthew Pangallo, Gregoire Ruffenach, Christine Marie Cunningham, Jeanette C. Perron, Srikanth Kolluru, Mansoureh Eghbali & Vivek Gupta. (2017) Advances in treatment of pulmonary arterial hypertension: patent review. Expert Opinion on Therapeutic Patents 27:8, pages 907-918.
Read now
Rui Chen, Jinchuan Yan, Peijing Liu, Zhongqun Wang, Cuiping Wang, Wei Zhong & Liangjie Xu. (2017) The role of nuclear factor of activated T cells in pulmonary arterial hypertension. Cell Cycle 16:6, pages 508-514.
Read now
Pravin B Sehgal. (2013) Non-genomic STAT5-dependent effects at the endoplasmic reticulum and Golgi apparatus and STAT6-GFP in mitochondria. JAK-STAT 2:4.
Read now

Articles from other publishers (49)

Manivannan Yegambaram, Xutong Sun, Qing Lu, Yan Jin, Wojciech Ornatowski, Jamie Soto, Saurabh Aggarwal, Ting Wang, Kim Tieu, Haiwei Gu, Jeffrey R. Fineman & Stephen M. Black. (2024) Mitochondrial hyperfusion induces metabolic remodeling in lung endothelial cells by modifying the activities of electron transport chain complexes I and III. Free Radical Biology and Medicine 210, pages 183-194.
Crossref
Chenchen Liu, Naifu Wan, Lijiang Wei, Wuwei Rong, Wentong Zhu, Meifeng Xie, Yanling Zhang, Zhihua Liu, Qing Jing & Ankang Lyu. (2023) Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension. Vascular Pharmacology 153, pages 107233.
Crossref
John S. Harrington, Stefan W. Ryter, Maria Plataki, David R. Price & Augustine M. K. Choi. (2023) Mitochondria in health, disease, and aging. Physiological Reviews 103:4, pages 2349-2422.
Crossref
Limin Chai, Qingting Wang, Yan Wang, Danyang Li, Qianqian Zhang, Yuqian Chen, Jin Liu, Huan Chen, Yuanjie Qiu, Nirui Shen, Jian Wang, Xinming Xie & Manxiang Li. (2023) Downregulation of PDCD4 through STAT3/ATF6/autophagy mediates MIF-induced PASMCs proliferation/migration and vascular remodeling. European Journal of Pharmacology 956, pages 175968.
Crossref
Chen Zhang, Yue Sun, Yingying Guo, Jingjing Xu & Haiyan Zhao. (2023) JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension. Cell Death Discovery 9:1.
Crossref
Akiko Kawade, Aya Yamamura, Rubii Kondo, Yoshiaki Suzuki & Hisao Yamamura. (2023) Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling. Journal of Pharmacological Sciences 151:2, pages 119-127.
Crossref
Jakob Körbelin, Julius Klein, Christiane Matuszcak, Johannes Runge, Lars Harbaum, Hans Klose & Jan K. Hennigs. (2023) Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential. Frontiers in Cardiovascular Medicine 9.
Crossref
Lars Harbaum, Christopher J. RhodesJohn WhartonAllan Lawrie, Jason H. KarnesAnkit A. DesaiWilliam C. NicholsMarc HumbertDavid Montani, Barbara GirerdOlivier Sitbon, Mario BoehmTatyana NovoyatlevaRalph T. SchermulyH. Ardeschir GhofraniMark ToshnerDavid G. KielyLuke S. HowardEmilia M. SwietlikStefan Gräf, Maik Pietzner, Nicholas W. MorrellMartin R. Wilkins, L Southgate, RD Machado, J Martin, WH Ouwehand, MW Pauciulo, A Arora, K Lutz, F Ahmad, SL Archer, R Argula, ED Austin, D Badesch, S Bakshi, C Barnett, R Benza, N Bhatt, CD Burger, M Chakinala, J Elwing, T Fortin, RP Frantz, A Frost, JGN Garcia, J Harley, H He, NS Hill, R Hirsch, D Ivy, J Klinger, T Lahm, K Marsolo, LJ Martin, SD Nathan, RJ Oudiz, Z Rehman, I Robbins, DM Roden, EB Rosenzweig, G Saydain, R Schilz, RW Simms, M Simon, H Tang, AY Tchourbanov, T Thenappan, F Torres, AK Walsworth, RE Walter, RJ White, J Wilt, D Yung, R Kittles, J Aman, J Knight, KB Hanscombe, H Gall, A Ulrich, HJ Bogaard, C Church, JG Coghlan, R Condliffe, PA Corris, C Danesino, CG Elliott, A Franke, S Ghio, JSR Gibbs, AC Houweling, G Kovacs, M Laudes, RV MacKenzie Ross, S Moledina, M Newnham, A Olschewski, H Olschewski, AJ Peacock, J Pepke-Zaba, L Scelsi, W Seeger, CM Shaffer, O Sitbon, J Suntharalingam, C Treacy, A Vonk Noordegraaf, Q Waisfisz, SJ Wort, RC Trembath, M Germain, I Cebola, J Ferrer, P Amouyel, S Debette, M Eyries, F Soubrier & DA Trégouët. (2022) Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 205:12, pages 1449-1460.
Crossref
Marta T. Gomes, Yang Bai, Simone R. Potje, Lu Zhang, Angelia D. Lockett & Roberto F. Machado. (2022) Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling. International Journal of Molecular Sciences 23:5, pages 2410.
Crossref
Keizo Hiraishi, Lin Hai Kurahara, Kaori Ishikawa, Tetsuhiko Go, Naoya Yokota, Yaopeng Hu, Takayuki Fujita, Ryuji Inoue & Katsuya Hirano. (2022) Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension. Journal of Smooth Muscle Research 58:0, pages 50-62.
Crossref
Xiao-Yue Ge, Tian-Tian Zhu, Mao-Zhong Yao, Hong Liu, Qian Wu, Jie Qiao, Wei-Fang Zhang & Chang-Ping Hu. (2021) MicroRNA-137 Inhibited Hypoxia-Induced Proliferation of Pulmonary Artery Smooth Muscle Cells by Targeting Calpain-2. BioMed Research International 2021, pages 1-15.
Crossref
Malik Bisserier, Michael G. Katz, Carlos Bueno-Beti, Agnieszka Brojakowska, Shihong Zhang, Sarah Gubara, Erik Kohlbrenner, Shahood Fazal, Anthony Fargnoli, Peter Dorfmuller, Marc Humbert, Akiko Hata, David A. Goukassian, Yassine Sassi & Lahouaria Hadri. (2021) Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension. International Journal of Molecular Sciences 22:17, pages 9105.
Crossref
Fei SunGuolun WangArun PradhanKui XuJose Gomez-ArroyoYufang ZhangGregory T. KalinZicheng Deng, Ronald J. VagnozziHua HeAndrew W. DunnYuhua WangAllen J. York, Rashmi S. HegdeJason C. WoodsTanya V. KalinJeffery D. Molkentin & Vladimir V. Kalinichenko. (2021) Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia. Circulation 144:7, pages 539-555.
Crossref
Inés Roger, Javier Milara, Paula Montero & Julio Cortijo. (2021) The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension. International Journal of Molecular Sciences 22:9, pages 4980.
Crossref
Yuan Li, Xiuzhi Yang, Qi Sun, Bide Duan & Yanyun Wang. (2020) The bioflavonoid troxerutin prevents gestational hypertension in mice by inhibiting STAT3 signaling. Hypertension Research 44:4, pages 399-406.
Crossref
Li Zhang, Xi‐Xi Zeng, Yu‐Mei Li, Shao‐Kun Chen, Li‐Yu Tang, Nan Wang, Xi Yang & Mo‐Jun Lin. (2020) Keratin 1 attenuates hypoxic pulmonary artery hypertension by suppressing pulmonary artery media smooth muscle expansion. Acta Physiologica 231:2.
Crossref
Andrew J. Bryant, Ann Pham, Himanshu Gogoi, Carly R. Mitchell, Faye Pais & Lei Jin. (2021) The Third Man: DNA sensing as espionage in pulmonary vascular health and disease. Pulmonary Circulation 11:1, pages 1-16.
Crossref
Dinesh Yerabolu, Astrid Weiss, Baktybek Kojonazarov, Mario Boehm, Beate Christiane Schlueter, Clemens Ruppert, Andreas Günther, Danny Jonigk, Friedrich Grimminger, Hossein-Ardeschir Ghofrani, Werner Seeger, Norbert Weissmann & Ralph Theo Schermuly. (2021) Targeting Jak–Stat Signaling in Experimental Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology 64:1, pages 100-114.
Crossref
Astrid Weiss, Mario Boehm, Bakytbek Egemnazarov, Friedrich Grimminger, Soni Savai Pullamsetti, Grazyna Kwapiszewska & Ralph T. Schermuly. (2020) Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction. British Journal of Pharmacology 178:1, pages 31-53.
Crossref
Mario Boehm & Ralph T. Schermuly. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1328 1336 .
Mario Boehm & Ralph T. Schermuly. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 8 .
Gesheng Cheng, Lu He & Yushun Zhang. (2020) LincRNA-Cox2 promotes pulmonary arterial hypertension by regulating the let-7a-mediated STAT3 signaling pathway. Molecular and Cellular Biochemistry 475:1-2, pages 239-247.
Crossref
Cássia Lisboa Braga, Nathane Santanna Felix, Douglas Esteves Teixeira, Juliana Borges Vieira, Rodrigo Pacheco Silva-Aguiar, Rebecca Madureira Bose, Mariana Alves Antunes, Nazareth de Novaes Rocha, Celso Caruso-Neves, Fernanda Ferreira Cruz, Patricia Rieken Macedo Rocco & Pedro Leme Silva. (2020) Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension. European Journal of Pharmacology 887, pages 173438.
Crossref
Mateusz K. Hołda, Aneta Stachowicz, Maciej Suski, Dorota Wojtysiak, Natalia Sowińska, Zbigniew Arent, Natalia Palka, Piotr Podolec & Grzegorz Kopeć. (2020) Myocardial proteomic profile in pulmonary arterial hypertension. Scientific Reports 10:1.
Crossref
Christina A. EichstaedtHeimo MairbäurlJie SongNicola BenjaminChristine FischerChristoph DehnertKai SchommerMarc M. BergerPeter BärtschEkkehard GrünigKatrin Hinderhofer. (2020) Genetic Predisposition to High-Altitude Pulmonary Edema. High Altitude Medicine & Biology 21:1, pages 28-36.
Crossref
Tengteng Zhu, Jun Luo, Yi Wang, Xianliang Xiong, Bin Sheng, Xiaojie Yang, Nsusu A. Mpembe Tresor Ndongala & Jiang Li. (2019) Elevated plasma Pim‐1 and its clinical significance in patients with pulmonary arterial hypertension. Clinical and Experimental Pharmacology and Physiology 46:8, pages 752-760.
Crossref
Hui Gao, Jiwang Chen, Tianji Chen, Yifang Wang, Yang Song, Yangbasai Dong, Shuangping Zhao & Roberto F. Machado. (2019) MicroRNA410 Inhibits Pulmonary Vascular Remodeling via Regulation of Nicotinamide Phosphoribosyltransferase. Scientific Reports 9:1.
Crossref
Benoît Ranchoux, Valerie Nadeau, Alice Bourgeois, Steeve PROVENCHER, Eve Tremblay, Junichi Omura, Nancy Côté, Rami Abu-Alhayja'a, Valérie Dumais, Renato Tadeu Nachbar, Lionel Tastet, Abdellaziz Dahou, Sandra Breuils-Bonnet, André Marette, Philippe Pibarot, Jocelyn Dupuis, Olivier boucherat, Roxane paulin, Stephen L Archer, Sébastien Bonnet & Francois Potus. (2019) Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease. Circulation Research.
Crossref
Louise Montalva, Lina Antounians & Augusto Zani. (2019) Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling. Pediatric Research 85:6, pages 754-768.
Crossref
Cheng‐Jun Hu, Hui Zhang, Aya Laux, Soni S. Pullamsetti & Kurt R. Stenmark. (2018) Mechanisms contributing to persistently activated cell phenotypes in pulmonary hypertension. The Journal of Physiology 597:4, pages 1103-1119.
Crossref
Yi-Tao Zhang, Jiao-Jie Xue, Qing Wang, Shi-Yao Cheng, Zhi-Chong Chen, Hua-Yang Li, Jia-Jie Shan, Kang-Lin Cheng & Wei-Jie Zeng. (2019) Dehydroepiandrosterone attenuates pulmonary artery and right ventricular remodeling in a rat model of pulmonary hypertension due to left heart failure. Life Sciences 219, pages 82-89.
Crossref
Zhengjiang Qian, Yanjiao Li, Haiyang Yang, Jidong Chen, Xiang Li & Deming Gou. (2018) PDGFBB promotes proliferation and migration via regulating miR-1181/STAT3 axis in human pulmonary arterial smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 315:6, pages L965-L976.
Crossref
Li Huang, Li Li, Tao Yang, Wen Li, Li Song, Xianmin Meng, Qing Gu, Changming Xiong & Jianguo He. (2018) Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease. Journal of Cellular and Molecular Medicine 22:12, pages 6249-6261.
Crossref
Khama’al Hussein Abod Al-Khafaji, Mohammed Noori Al-Dujaili & Arshad Noori Ghani Al-Dujaili. (2018) Assessment of noggin level in pulmonary arterial hypertension patients. Current Issues in Pharmacy and Medical Sciences 31:3, pages 122-130.
Crossref
Andrew Bryant, Borna Mehrad, Todd Brusko, James West & Lyle Moldawer. (2018) Myeloid-Derived Suppressor Cells and Pulmonary Hypertension. International Journal of Molecular Sciences 19:8, pages 2277.
Crossref
Jeffrey D. Marshall, Isabel Bazan, Yi Zhang, Wassim H. Fares & Patty J. Lee. (2018) Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both. American Journal of Physiology-Lung Cellular and Molecular Physiology 314:5, pages L782-L796.
Crossref
Wolfgang M. Kuebler, Sébastien Bonnet & Arata Tabuchi. (2018) Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series). Pulmonary Circulation 8:2, pages 1-13.
Crossref
Xiaoping Zhang, Runxia Shao, Weiwei Gao, Guanghao Sun, Ying Liu & Xian’en Fa. (2018) Inhibition of miR-361-5p suppressed pulmonary artery smooth muscle cell survival and migration by targeting ABCA1 and inhibiting the JAK2/STAT3 pathway. Experimental Cell Research 363:2, pages 255-261.
Crossref
Peng Gao, Na Niu, Tianshu Wei, Hideto Tozawa, Xiaocui Chen, Caiqing Zhang, Jiandong Zhang, Youichiro Wada, Carolyn M. Kapron & Ju Liu. (2017) The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis. Oncotarget 8:40, pages 69139-69161.
Crossref
Nilesh Gupta, Jahidur Rashid, Eva Nozik-Grayck, Ivan F. McMurtry, Kurt R. Stenmark & Fakhrul Ahsan. (2017) Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency. Molecular Pharmaceutics 14:3, pages 830-841.
Crossref
Inderjit Singh, Geoffrey Mikita, Daniel Green, Cristobal Risquez & Abraham Sanders. (2017) Pulmonary extra‐medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series. Pulmonary Circulation 7:1, pages 261-267.
Crossref
Adolf Koudelka, Gabriela Ambrozova, Anna Klinke, Tana Fidlerova, Hana Martiskova, Radek Kuchta, Tanja K. Rudolph, Jaroslav Kadlec, Zdenka Kuchtova, Steven R. Woodcock, Bruce A. Freeman, Lukas Kubala & Michaela Pekarova. (2016) Nitro-Oleic Acid Prevents Hypoxia- and Asymmetric Dimethylarginine-Induced Pulmonary Endothelial Dysfunction. Cardiovascular Drugs and Therapy 30:6, pages 579-586.
Crossref
Ran Wang, Xing Ding, Sijing Zhou, Min Li, Li Sun, Xuan Xu & Guanghe Fei. (2016) MicroRNA-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1). Oncotarget 7:45, pages 72746-72757.
Crossref
Benoît Ranchoux, Jolyane Meloche, Roxane Paulin, Olivier Boucherat, Steeve Provencher & Sébastien Bonnet. (2016) DNA Damage and Pulmonary Hypertension. International Journal of Molecular Sciences 17:6, pages 990.
Crossref
Frédéric Perros & Sébastien Bonnet. (2015) Bone Morphogenetic Protein Receptor Type II and Inflammation Are Bringing Old Concepts into the New Pulmonary Arterial Hypertension World. American Journal of Respiratory and Critical Care Medicine 192:7, pages 777-779.
Crossref
Elaine Soon, Alexi Crosby, Mark Southwood, Peiran Yang, Tamara Tajsic, Mark Toshner, Sarah Appleby, Catherine M. Shanahan, Kenneth D. Bloch, Joanna Pepke-Zaba, Paul Upton & Nicholas W. Morrell. (2015) Bone Morphogenetic Protein Receptor Type II Deficiency and Increased Inflammatory Cytokine Production. A Gateway to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 192:7, pages 859-872.
Crossref
Jochen Dutzmann, Jan-Marcus Daniel, Johann Bauersachs, Denise Hilfiker-Kleiner & Daniel G. Sedding. (2015) Emerging translational approaches to target STAT3 signalling and its impact on vascular disease. Cardiovascular Research 106:3, pages 365-374.
Crossref
Jiwang Chen, Haiyang Tang, Justin R. Sysol, Liliana Moreno-Vinasco, Krystyna M. Shioura, Tianji Chen, Irina Gorshkova, Lichun Wang, Long Shuang Huang, Peter V. Usatyuk, Saad Sammani, Guofei Zhou, J. Usha Raj, Joe G. N. Garcia, Evgeny Berdyshev, Jason X.-J. Yuan, Viswanathan Natarajan & Roberto F. Machado. (2014) The Sphingosine Kinase 1/Sphingosine-1-Phosphate Pathway in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 190:9, pages 1032-1043.
Crossref
Karim C. El Kasmi, Steven C. Pugliese, Suzette R. Riddle, Jens M. Poth, Aimee L. Anderson, Maria G. Frid, Min Li, Soni S. Pullamsetti, Rajkumar Savai, Maria A. Nagel, Mehdi A. Fini, Brian B. Graham, Rubin M. Tuder, Jacob E. Friedman, Holger K. Eltzschig, Ronald J. Sokol & Kurt R. Stenmark. (2014) Adventitial Fibroblasts Induce a Distinct Proinflammatory/Profibrotic Macrophage Phenotype in Pulmonary Hypertension. The Journal of Immunology 193:2, pages 597-609.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.